Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Stephen A. Munk is active.

Publication


Featured researches published by Stephen A. Munk.


Bioorganic & Medicinal Chemistry Letters | 1995

Analogs of UK 14,304: Structural features responsible for α2 adrenoceptor activity

Stephen A. Munk; Dale A. Harcourt; P. Arasasingham; Charles Gluchowski; H. Wong; James E. Burke; Alexander B. Kharlamb; Cynthia A. Manlapaz; Edwin U. Padillo; L. Williams; Larry A. Wheeler; Michael E. Garst

Abstract Factors influencing the potency of UK 14,304 analogs including conformational preorganization and arrangement of hydrogen bond acceptors on the aromatic core are described. The previously reported importance of twist of the iminoimidazoline ring relative to the core for enhanced α 2 activity is supported.


Bioorganic & Medicinal Chemistry Letters | 1994

Analogs of UK 14,304 as α2-adrenoceptor agonists. Twist and agent polarity as design elements

Stephen A. Munk; Charles Gluchowski; L. Dolby; H. Wong; James E. Burke; Alexander B. Kharlamb; Cynthia A. Manlapaz; Edwin U. Padillo; D. Rodgers; B. Ohta; Larry A. Wheeler; Michael E. Garst

Abstract Tetrahydroquinoxaline analogs of UK 14,304 were prepared. These agents proved to be highly polar, potent, and selective α 2 -adrenoceptor agonists. This study suggested that agents bearing a twist of the imidazoline ring relative to the quinoxaline nucleus prove more potent than planar analogs.


Archive | 1998

Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors

Ken Chow; Daniel W. Gil; James A. Burke; Dale A. Harcourt; Michael E. Garst; Larry A. Wheeler; Stephen A. Munk


Journal of Medicinal Chemistry | 1996

Synthesis and Pharmacologic Evaluation of 2-endo-Amino-3-exo- isopropylbicyclo[2.2.1]heptane: A Potent Imidazoline1 Receptor Specific Agent

Stephen A. Munk; Ronald K. Lai; James E. Burke; Premilla N. Arasasingham; Alexander B. Kharlamb; Cynthia A. Manlapaz; Edwin U. Padillo; Mercy Wijono; Dain W. Hasson; Larry A. Wheeler; Michael E. Garst


Archive | 2000

Compounds as selective agonists at alpha 2b or 2b/2c adrenergic receptors

Ken Chow; Daniel W. Gil; James A. Burke; Dale A. Harcourt; Michael E. Garst; Larry A. Wheeler; Stephen A. Munk


Archive | 2000

Methods of treating pain and other conditions

Ken Chow; Daniel W. Gil; James A. Burke; Dale A. Harcourt; Michael E. Garst; Larry A. Wheeler; Stephen A. Munk


Archive | 2002

Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors

Ken Chow; Daniel W. Gil; James A. Burke; Dale A. Harcourt; Michael E. Garst; Larry A. Wheeler; Stephen A. Munk; Dario G. Gomez


Archive | 2001

Imidiazoles having reduced side effects

Ken Chow; Daniel W. Gil; James A. Burke; Dale A. Harcourt; Michael E. Garst; Larry A. Wheeler; Stephen A. Munk; Dario G. Gomez; Todd M. Heidelbaugh


Journal of Medicinal Chemistry | 1997

Synthesis and evaluation of 2-(arylamino)imidazoles as α2-adrenergic agonists

Stephen A. Munk; Dale A. Harcourt; Premilla N. Arasasingham; James A. Burke; Alexander B. Kharlamb; Cynthia A. Manlapaz; Edwin U. Padillo; Donald Roberts; Eileen Runde; Linda Williams; Larry A. Wheeler; Michael E. Garst


Experimental Eye Research | 1997

Mechanisms of adrenergic agonist induced allergy bioactivation and antigen formation

Charles D. Thompson; Timothy L. Macdonald; Michael E. Garst; Anne Wiese; Stephen A. Munk

Collaboration


Dive into the Stephen A. Munk's collaboration.

Researchain Logo
Decentralizing Knowledge